Muscle wasting in disease: molecular mechanisms and promising therapies
The DOI matches its Crossref record; 255 of the 257 references it cites were found in a registry or an index.
Abstract
Atrophy occurs in specific muscles with inactivity (for example, during plaster cast immobilization) or denervation (for example, in patients with spinal cord injuries). Muscle wasting occurs systemically in older people (a condition known as sarcopenia); as a physiological response to fasting or malnutrition; and in many diseases, including chronic obstructive pulmonary disorder, cancer-associated cachexia, diabetes, renal failure, cardiac failure, Cushing syndrome, sepsis, burns and trauma. The rapid loss of muscle mass and strength primarily results from excessive protein breakdown, which is often accompanied by reduced protein synthesis. This loss of muscle function can lead to reduced quality of life, increased morbidity and mortality. Exercise is the only accepted approach to prevent or slow atrophy. However, several promising therapeutic agents are in development, and major advances in our understanding of the cellular mechanisms that regulate the protein balance in muscle include the identification of several cytokines, particularly myostatin, and a common transcriptional programme that promotes muscle wasting. Here, we discuss these new insights and the rationally designed therapies that are emerging to combat muscle wasting.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Evidence also indicates that RT can effectively mitigate LM or skeletal muscle mass loss associated with dietary interventions (75) and in response to disease states (76).This occurs independently of reductions in body weight and fat mass.”
From Incretin-Based Weight Loss Pharmacotherapy: Can Resistance Exercise Optimize Changes in Body Composition? (2024) · cites this paper as [75]
In the citing paper
“The muscle atrophy also occurs in cachexia, a comorbidity of abnormal conditions such as cancer, AIDS, congestive heart failure and chronic obstructive pulmonary disease, also occurs in sarcopenia, a decreases in muscle mass and strength associated with aging [61] .”
From Alternative Medicine: New Ways to Treat Diseases and Therapies (2021) · cites this paper as [61]
In the citing paper
“MuRF1 ubiquitinates several muscle structural proteins, including troponin I, myosin heavy chains, actin, myosin-binding protein C, and myosin light chains 1 and 242.”
From Mechanisms of muscle atrophy and hypertrophy: implications in health and disease (2021) · cites this paper as [42]
In the citing paper
“Because muscle loss requires the activation of transcription‐dependent programme controlled by the regulation of a subset of genes named atrophy‐related genes or atrogenes,36 we monitored several atrogenes mRNAs”
From Fibroblast growth factor 21 controls mitophagy and muscle mass (2019) · cites this paper as [36]
In the citing paper
“Skeletal muscle mass is controlled by a fine balance between protein synthesis and protein degradation processes triggered by changes in physical activity11,14,15, yet the intrinsic muscular signaling networks driving muscle mass loss particularly during the early phase of muscle disuse remain unclear.”
From Disuse-associated loss of the protease Lonp1 in muscle impairs mitochondrial function and causes reduced skeletal muscle mass and strength (2022) · cites this paper as [14]
4 more claims about this paper
Create a free account to see every claim other papers make about this one.
Citations
Cites
1 retracted
Wenz, T., Rossi, S. G., Rotundo, R. L., Spiegelman, B. M., & Moraes, C. T. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0911570106 · Cited by 600
RetractedLozano, R., Naghavi, M., Foreman, K., Lim, S., Shibuya, K., Aboyans, V., Abraham, J., Adair, T., Aggarwal, R., Ahn, S. Y., et al. (2012) · The Lancet · doi:10.1016/s0140-6736(12)61728-0 · Cited by 14,070
Regulation of skeletal muscle mass in mice by a new TGF-p superfamily member
McPherron, A. C., Lawler, A. M., & Lee, S.-J. (1997) · Nature · doi:10.1038/387083a0 · Cited by 4,013
Identification of ubiquitin ligases required for skeletal muscle atrophy.
Bodine, S. C., Latres, E., Baumhueter, S., Lai, V. K.-M., Nunez, L., Clarke, B. A., Poueymirou, W. T., Panaro, F. J., Na, E., Dharmarajan, K., et al. (2001) · Science · doi:10.1126/science.1065874 · Cited by 3,521
Sandri, M., Sandri, C., Gilbert, A., Skurk, C., Calabria, E., Picard, A., Walsh, K., Schiaffino, S., Lecker, S. H., & Goldberg, A. L. (2004) · Cell · doi:10.1016/s0092-8674(04)00400-3 · Cited by 3,012
Self-citationTranscriptional co-activator PGC-1α drives the formation of slow-twitch muscle fibres
Lin, J., Wu, H., Tarr, P. T., Zhang, C.-Y., Wu, Z., Boss, O., Michael, L. F., Puigserver, P., Isotani, E., Olson, E. N., et al. (2002) · Nature · doi:10.1038/nature00904 · Cited by 2,546
AMP-activated protein kinase (AMPK) action in skeletal muscle via direct phosphorylation of PGC-1α
Jäger, S., Handschin, C., St.-Pierre, J., & Spiegelman, B. M. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0705070104 · Cited by 2,491
Evans, W. J., Morley, J. E., Argilés, J., Bales, C., Baracos, V., Guttridge, D., Jatoi, A., Kalantar-Zadeh, K., Lochs, H., Mantovani, G., et al. (2008) · Clinical Nutrition · doi:10.1016/j.clnu.2008.06.013 · Cited by 2,450
Mammalian Sirtuins: Biological Insights and Disease Relevance
Haigis, M. C., & Sinclair, D. A. (2010) · Annual Review of Pathology: Mechanisms of Disease · doi:10.1146/annurev.pathol.4.110807.092250 · Cited by 2,085
FoxO3 Controls Autophagy in Skeletal Muscle In Vivo
Mammucari, C., Milan, G., Romanello, V., Masiero, E., Rudolf, R., Del Piccolo, P., Burden, S. J., Di Lisi, R., Sandri, C., Zhao, J., et al. (2007) · Cell Metabolism · doi:10.1016/j.cmet.2007.11.001 · Cited by 1,953
Self-citation
Research works printed but not linked: 1
- Arany, Z. et al. The transcriptional coactivator PGC-1β drives the formation of oxidative type IIX fibers in skeletal muscle. Cell Metab. 5, 35–46 (2007). · DOI · Paper page
Cited by
Items 301–400 of 1,000
Watson, E. L., Baker, L. A., Wilkinson, T. J., Gould, D. W., Xenophontos, S., Graham-Brown, M. P. M., Major, R., Ashford, R. U., Viana, J. L., & Smith, A. C. (2021) · Nephrology Dialysis Transplantation · doi:10.1093/ndt/gfab333 · Cited by 37
Inflammatory response during slow- and fast-twitch muscle regeneration
Zimowska, M., Kasprzycka, P., Bocian, K., Delaney, K., Jung, P., Kuchcinska, K., Kaczmarska, K., Gladysz, D., Stremińska, W., & Ciemerych, M. A. (2016) · Muscle & Nerve · doi:10.1002/mus.25246 · Cited by 38
Cxcl14 depletion accelerates skeletal myogenesis by promoting cell cycle withdrawal
Waldemer, R. J., Reyes‐Ordoñez, A., Kim, D., Zhang, R., Singh, N., & Chen, J. (2017) · npj Regenerative Medicine · doi:10.1038/npjregenmed.2016.17 · Cited by 39
Botsen, D., Ordan, M., Barbe, C., Mazza, C., Perrier, M., Moreau, J., Brasseur, M., Renard, Y., Taillière, B., Slimano, F., et al. (2018) · BMC Cancer · doi:10.1186/s12885-018-4860-1 · Cited by 37
Lala-Tabbert, N., Mrad, R. L., Timusk, K., Fukano, M., Holbrook, J., St-Jean, M., LaCasse, E. C., & Korneluk, R. G. (2019) · Skeletal Muscle · doi:10.1186/s13395-019-0201-6 · Cited by 39
Emerging proteomic biomarkers of X-linked muscular dystrophy
Dowling, P., Murphy, S., Zweyer, M., Raucamp, M., Swandulla, D., & Ohlendieck, K. (2019) · Expert Review of Molecular Diagnostics · doi:10.1080/14737159.2019.1648214 · Cited by 37
Schranner, D., Schönfelder, M., Römisch‐Margl, W., Scherr, J., Schlegel, J., Zelger, O., Riermeier, A., Bremer, S., Prehn, C. P., Adamski, J., et al. (2021) · Physiological Reports · doi:10.14814/phy2.14885 · Cited by 46
Proteomic profiling of muscle fibre type shifting in neuromuscular diseases
Dowling, P., Murphy, S., & Ohlendieck, K. (2016) · Expert Review of Proteomics · doi:10.1080/14789450.2016.1209416 · Cited by 41
Lung Cancer Cachexia: Can Molecular Understanding Guide Clinical Management?
Sørensen, J. (2018) · Integrative Cancer Therapies · doi:10.1177/1534735418781743 · Cited by 38
Taurine enhances skeletal muscle mitochondrial function in a rat model of resistance training
Ommati, M. M., Farshad, O., Jamshidzadeh, A., & Heidari, R. (2019) · PharmaNutrition · doi:10.1016/j.phanu.2019.100161 · Cited by 36
Hemojuvelin is a novel suppressor for Duchenne muscular dystrophy and age‐related muscle wasting
Zhang, P., He, J., Wang, F., Gong, J., Wang, L., Wu, Q., Li, W., Liu, H., Wang, J., Zhang, K., et al. (2019) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12414 · Cited by 46
Alsolmei, F. A., Li, H., Pereira, S. L., Krishnan, P., Johns, P. W., & Siddiqui, R. A. (2019) · Nutrients · doi:10.3390/nu11051077 · Cited by 37
Medical Cannabinoids for Cancer Cachexia: A Systematic Review and Meta-Analysis
Wang, J., Wang, Y., Tong, M., Pan, H., & Li, D. (2019) · BioMed Research International · doi:10.1155/2019/2864384 · Cited by 39
Macronutrients in Parenteral Nutrition: Amino Acids
Iacone, R., Scanzano, C., Santarpia, L., Cioffi, I., Contaldo, F., & Pasanisi, F. (2020) · Nutrients · doi:10.3390/nu12030772 · Cited by 46
Tu, S., Hao, X., Xu, S., Jin, X., Liao, W., Xia, H., Wang, S., & Sun, G. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26146740 · Cited by 51
HMGB1/autophagy pathway mediates the atrophic effect of TGF-β1 in denervated skeletal muscle
Yang, X., Xue, P., Liu, X., Xu, X., & Chen, Z. (2018) · Cell Communication and Signaling · doi:10.1186/s12964-018-0310-6 · Cited by 39
Wu, Y., Wang, Y., Wu, W., Yin, D., Sun, X., Guo, X., Chen, J., Mahmood, T., Yan, L., & Yuan, J. (2019) · Poultry Science · doi:10.1016/j.psj.2019.10.070 · Cited by 34
Hitachi, K., Nakatani, M., Funasaki, S., Hijikata, I., Maekawa, M., Honda, M., & Tsuchida, K. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051628 · Cited by 39
Millward, D. J. (2021) · Nutrients · doi:10.3390/nu13030729 · Cited by 49
Jin, J., Du, M., Wang, J., Guo, Y., Zhang, J., Zuo, H., Hou, Y., Wang, S., Lv, W., Bai, W., et al. (2022) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13012 · Cited by 37
Bioenergetic Impairment in Congenital Muscular Dystrophy Type 1A and Leigh Syndrome Muscle Cells
de Oliveira, C. C. F., Steinz, M. M., Schneiderat, P., Mulder, H., & Durbeej, M. (2017) · Scientific Reports · doi:10.1038/srep45272 · Cited by 36
The Role of Exercise in Cancer-Related Sarcopenia and Sarcopenic Obesity
Papadopetraki, A., Giannopoulos, A., Maridaki, M., Zagouri, F., Droufakou, S., Koutsilieris, M., & Philippou, A. (2023) · Cancers · doi:10.3390/cancers15245856 · Cited by 34
Sharma, B., Dutt, V., Kaur, N., Mittal, A., & Dabur, R. (2020) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2020.112720 · Cited by 34
Corylifol A from Psoralea corylifolia L. Enhances Myogenesis and Alleviates Muscle Atrophy
Han, Y., Lee, H., Li, H., & Ryu, J.-H. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21051571 · Cited by 34
Delafontaine, P., & Yoshida, T. (2016) · PubMed · Cited by 41
Tolloid cleavage activates latent GDF8 by priming the pro‐complex for dissociation
Le, V. Q., Iacob, R. E., Tian, Y., McConaughy, W., Jackson, J., Su, Y., Zhao, B., Engen, J. R., Pirruccello, M., & Springer, T. A. (2018) · The EMBO Journal · doi:10.15252/embj.201797931 · Cited by 33
Molecular regulation of skeletal muscle mass and the contribution of nitric oxide: A review
Kobayashi, J., Uchida, H., Kofuji, A., Ito, J., Shimizu, M., Kim, H., Sekiguchi, Y., & Kushibe, S. (2019) · FASEB BioAdvances · doi:10.1096/fba.2018-00080 · Cited by 40
Yeon, M., Choi, H., & Jun, H. (2020) · Nutrients · doi:10.3390/nu12051255 · Cited by 38
Nagashima, T., Hadiwidjaja, S., Ohsumi, S., Murata, A., Hisada, T., Kato, R., Okada, Y., Honda, H., & Shimizu, K. (2020) · Advanced Biosystems · doi:10.1002/adbi.202000121 · Cited by 40
Angiotensin II-induced muscle atrophy via PPARγ suppression is mediated by miR-29b
Jin, L., Yang, T., Sha, Z., Tang, H., Hua, X., Wang, L., Wang, Z., Gao, Z., Sluijter, J. P. G., Rowe, G. C., et al. (2020) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2020.12.015 · Cited by 35
Wang, C., Zhao, B., Zhai, J., Wang, A., Cao, N., Liao, T., Su, R., He, L., Li, Y., Pei, X., et al. (2023) · Cell Death and Disease · doi:10.1038/s41419-023-05843-8 · Cited by 39
Dietary Intake of Probiotic Kimchi Ameliorated Il-6-Driven Cancer Cachexia
An, J. M., Kang, E. A., Han, Y.-M., Oh, J. Y., Lee, D. Y., Choi, S. H., Kim, D. H., & Hahm, K. B. (2019) · Journal of Clinical Biochemistry and Nutrition · doi:10.3164/jcbn.19-10 · Cited by 33
Impact of blood flow‐restricted bodyweight exercise on skeletal muscle adaptations
Jakobsgaard, J. E., Christiansen, M., Sieljacks, P., Wang, J., Groennebaek, T., de Paoli, F., & Vissing, K. (2018) · Clinical Physiology and Functional Imaging · doi:10.1111/cpf.12509 · Cited by 33
“chronic inflammatory diseases (such as rheumatoid arthritis) and/or increased age (Evans, 2010; Cohen et al., 2015).”
BackgroundLi, Z., Qi, Y., Sun, L., Li, Z., Chen, S., Zhang, Y., Ma, Y., Han, J., Wang, Z., Zhang, Y., et al. (2023) · Theranostics · doi:10.7150/thno.87288 · Cited by 37
Prosarcopenic Effects of Statins May Limit Their Effectiveness in Patients with Heart Failure
Bielecka-Dabrowa, A. M., Fabiś, J., Mikhailidis, D. P., von Haehling, S., Sahebkar, A., Rysz, J., & Banach, M. (2018) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2018.02.003 · Cited by 31
The role of IL-1 in adipose browning and muscle wasting in CKD-associated cachexia
Cheung, W. W., Zheng, R., Sheng, H., Wang, Z., Gonzalez, A., Zhou, P. H., Hoffman, H. M., & MAK, R. H. K. (2021) · Scientific Reports · doi:10.1038/s41598-021-94565-y · Cited by 37
Osteopontin - The stirring multifunctional regulatory factor in multisystem aging
Du, Y.-X., Mao, L., Wang, Z.-K., Yan, K., Zhang, L., & Zou, J. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.1014853 · Cited by 34
Exercise prevents impaired autophagy and proteostasis in a model of neurogenic myopathy
Campos, J. C., Baehr, L. M., Gomes, K. M. S., Bechara, L. R. G., Voltarelli, V. A., Bozi, L. H. M., Ribeiro, M. A. C., Ferreira, N. D., Moreira, J. B. N., Brum, P. C., et al. (2018) · Scientific Reports · doi:10.1038/s41598-018-30365-1 · Cited by 32
Rodriguez, J., Caille, O., Ferreira, D., & Francaux, M. (2017) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.201600169 · Cited by 32
Oncostatin M signaling drives cancer-associated skeletal muscle wasting
Domaniku, A., Agca, S., Toledo, B., Sucuoglu, M., Özen, S. D., Bilgiç, Ş. N., Arabacı, D. H., Kashgari, A. E., & Kır, S. (2024) · Cell Reports Medicine · doi:10.1016/j.xcrm.2024.101498 · Cited by 43
Attia, M., Maurer, M., Robinet, M., Grand, F. L., Fadel, É., Panse, R. L., Butler-Browne, G. S., & Berrih‐Aknin, S. (2017) · Acta Neuropathologica · doi:10.1007/s00401-017-1754-2 · Cited by 36
Myostatin inhibition prevents skeletal muscle pathophysiology in Huntington’s disease mice
Bondulich, M. K., Jolinon, N., Osborne, G. F., Smith, E. J., Rattray, I., Neueder, A., Sathasivam, K., Ahmed, M., Ali, N. S., Benjamin, A. C., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-14290-3 · Cited by 57
Enhancement Strategies for Cardiac Regenerative Cell Therapy: Focus on Adult Stem Cells
Broughton, K. M., & Sussman, M. A. (2018) · Circulation Research · doi:10.1161/circresaha.118.311207 · Cited by 36
Critical Illness and the Frailty Syndrome: Mechanisms and Potential Therapeutic Targets
Paul, J. A., Whittington, R. A., & Baldwin, M. R. (2020) · Anesthesia & Analgesia · doi:10.1213/ane.0000000000004792 · Cited by 44
Impact of Cancer Cachexia on Cardiac and Skeletal Muscle: Role of Exercise Training
Bordignon, C., dos Santos, B. S., & Rosa, D. D. (2022) · Cancers · doi:10.3390/cancers14020342 · Cited by 34
Delivery of engineered extracellular vesicles with miR-29b editing system for muscle atrophy therapy
Chen, R., Yuan, W., Zheng, Y., Zhu, X., Jin, B., Yang, T., Yan, Y., Xu, W., Chen, H., Gao, J., et al. (2022) · Journal of Nanobiotechnology · doi:10.1186/s12951-022-01508-4 · Cited by 36
Rho GTPases in Skeletal Muscle Development and Homeostasis
Rodríguez‐Fdez, S., & Bustelo, X. R. (2021) · Cells · doi:10.3390/cells10112984 · Cited by 35
Won, D. D., Cho, Y., Jeon, M.-J., Kim, J., Lee, I. J., Youn, Y. H., Park, J. J., Jung, D. H., Park, H., Lee, C. G., et al. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00366 · Cited by 34
Role and mechanism of catechin in skeletal muscle cell differentiation
Li, P., Liu, A., Liu, C., Qu, Z., Xiao, W., Huang, J., Liu, Z., & Zhang, S. (2019) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2019.108225 · Cited by 31
MEF2 impairment underlies skeletal muscle atrophy in polyglutamine disease
Nath, S. R., Lieberman, M. L., Yu, Z., Marchioretti, C., Jones, S. T., Danby, E. C. E., Pelt, K. M. V., Sorarú, G., Robins, D. M., Bates, G. P., et al. (2020) · Acta Neuropathologica · doi:10.1007/s00401-020-02156-4 · Cited by 32
Rivera, J. C. A., Ábrigo, J., Tacchi, F., Simón, F., Brandan, E., Santos, R. A. S., Bäder, M., Chiong, M., & Cabello‐Verrugio, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21249344 · Cited by 32
Makhnovskii, P. A., Bokov, R. O., Kolpakov, F., & Popov, D. V. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031208 · Cited by 36
Kobak, K. A., Lawrence, M. M., Pharaoh, G. A., Borowik, A., Peelor, F. F., Shipman, P. D., Griffin, T. M., Remmen, H. V., & Miller, B. F. (2021) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12772 · Cited by 32
Gouez, M., Delrieu, L., Bouleuc, C., Girard, N., Raynard, B., & Marchal, T. (2022) · Cancers · doi:10.3390/cancers14143439 · Cited by 35
Hinds, T. D., Peck, B. D., Shek, E., Stroup, S., Hinson, J., Arthur, S. T., & Marino, J. S. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17020232 · Cited by 33
Salanova, M., Gambara, G., Moriggi, M., Vasso, M., Ungethuem, U., Belavý, D. L., Felsenberg, D., Cerretelli, P., Gelfi, C., & Blottner, D. (2015) · Scientific Reports · doi:10.1038/srep17027 · Cited by 30
Modeling the transport of nuclear proteins along single skeletal muscle cells
Taylor‐Weiner, H., Grigsby, C. L., Ferreira, D. M. S., Dias, J. M. M., Stevens, M. M., Ruas, J. L., & Teixeira, A. I. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1919600117 · Cited by 33
Yoshioka, Y., Samukawa, Y., Yamashita, Y., & Ashida, H. (2020) · Food & Function · doi:10.1039/d0fo00720j · Cited by 30
Linalool Prevents Cisplatin Induced Muscle Atrophy by Regulating IGF-1/Akt/FoxO Pathway
Zhang, H., Chi, M., Chen, L., Sun, X., Wan, L., Yang, Q., & Guo, C. (2020) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.598166 · Cited by 32
Nakanishi, N., Tsutsumi, R., Hara, K., Matsuo, M., Sakaue, H., & Oto, J. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10040614 · Cited by 33
Firearms-related skeletal muscle trauma: pathophysiology and novel approaches for regeneration
Moriscot, A. S., Miyabara, E. H., Langeani, B., Belli, A., Egginton, S., & Bowen, T. S. (2021) · npj Regenerative Medicine · doi:10.1038/s41536-021-00127-1 · Cited by 39
Zhang, X., Xie, W., Chen, L., Xu, G., Wu, L., Li, Y., & Wu, Y. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.894996 · Cited by 40
Langkilde, A., Petersen, J., Henriksen, J. H., Jensen, F. K., Gerstoft, J., Eugen‐Olsen, J., & Andersen, O. (2015) · Immunity & Ageing · doi:10.1186/s12979-015-0036-x · Cited by 33
Lunar gravity prevents skeletal muscle atrophy but not myofiber type shift in mice
Hayashi, T., Fujita, R., Okada, R., Hamada, M., Suzuki, R., Fuseya, S., Leckey, J., Kanai, M., Inoue, Y., Sadaki, S., et al. (2023) · Communications Biology · doi:10.1038/s42003-023-04769-3 · Cited by 35
Raoul, P. C., Cintoni, M., Coppola, A., Alfieri, S., Tortora, G., Gasbarrini, A., Mele, M. C., & Rinninella, E. (2023) · International Journal of Surgery · doi:10.1097/js9.0000000000000989 · Cited by 31
Tewari, N., Awad, S., Duška, F., Williams, J. P., Bennett, A. J., Macdonald, I. A., & Lobo, D. N. (2018) · Clinical Nutrition · doi:10.1016/j.clnu.2018.01.032 · Cited by 33
Yoo, A., Jang, Y. J., Ahn, J., Jung, C. H., Seo, H., & Ha, T. Y. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21082811 · Cited by 29
Hughes, D. C., Baehr, L. M., Driscoll, J., Lynch, S. A., Waddell, D. S., & Bodine, S. C. (2020) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00253.2020 · Cited by 33
Ginseng and ginsenosides: Therapeutic potential for sarcopenia
Zha, W., Sun, Y., Gong, W., Li, L., Kim, W., & Li, H. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113876 · Cited by 33
Molecular mechanisms of post‐burn muscle wasting and the therapeutic potential of physical exercise
Dombrecht, D., Daele, U. V., Asbroeck, B. V., Schieffelers, D. R., Guns, P., Gebruers, N., Meirte, J., & van Breda, E. (2023) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.13188 · Cited by 31
Kashiwagi, S., Khan, M. A. S., Yasuhara, S., Goto, T., Kem, W. R., Tompkins, R. G., Kaneki, M., & Martyn, J. A. J. (2016) · Shock · doi:10.1097/shk.0000000000000729 · Cited by 32
Fourier‐transform ion cyclotron resonance mass spectrometry for characterizing proteoforms
Tucholski, T., & Ge, Y. (2020) · Mass Spectrometry Reviews · doi:10.1002/mas.21653 · Cited by 30
Edmunds, K. J., Árnadóttir, Í., Gíslason, M. K., Carraro, U., & Gargiulo, P. (2016) · Computational and Mathematical Methods in Medicine · doi:10.1155/2016/8932950 · Cited by 31
Dagbay, K. B., Treece, E. R., Streich, F. C., Jackson, J., Faucette, R., Nikiforov, A., Lin, S. C., Boston, C., Nicholls, S. B., Capili, A. D., et al. (2020) · Journal of Biological Chemistry · doi:10.1074/jbc.ra119.012293 · Cited by 33
IgLON5 Regulates the Adhesion and Differentiation of Myoblasts
Lim, J. H., Beg, M. M. A., Ahmad, K., Shaikh, S., Ahmad, S. S., Chun, H. J., Choi, D., Lee, W., Jin, J., Kim, J., et al. (2021) · Cells · doi:10.3390/cells10020417 · Cited by 31
Sarcopenia in Hepatocellular Carcinoma: Pathogenesis and Management
Gallo, P., Silletta, M., Vincentis, A. D., Prinzi, F. L., Terracciani, F., Fazio, G. R. D., Flagiello, V., Gentilucci, U. V., Incalzi, R. A., & Picardi, A. (2021) · Chemotherapy · doi:10.1159/000521741 · Cited by 31
Optimal timing of introducing mobilization therapy for ICU patients with sepsis
Liu, K., Shibata, J., Fukuchi, K., Takahashi, K., Sonoo, T., Ogura, T., & Goto, T. (2022) · Journal of Intensive Care · doi:10.1186/s40560-022-00613-8 · Cited by 31
High Intensity Interval Training: A Potential Method for Treating Sarcopenia
Liu, Q., Xie, W., Luo, Y., Li, Y., Huang, W., Wu, Y., & Li, Y. (2022) · Clinical Interventions in Aging · doi:10.2147/cia.s366245 · Cited by 37
Sarcopenia in chronic kidney disease: from bench to bedside
Kim, D. W., & Song, S. H. (2023) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2022.338 · Cited by 39
Update on the treatment of cancer cachexia
Nishie, K., Nishie, T., Sato, S., & Hanaoka, M. (2023) · Drug Discovery Today · doi:10.1016/j.drudis.2023.103689 · Cited by 29
Comparative Proteomic and Transcriptomic Analysis of Follistatin-Induced Skeletal Muscle Hypertrophy
Barbé, C., Bray, F., Gueugneau, M., Flament, S., Lause, P., Tokarski, C., Rolando, C. H., & Thissen, J. (2017) · Journal of Proteome Research · doi:10.1021/acs.jproteome.7b00069 · Cited by 31
Exploring the Role of Extracellular Vesicles in Skeletal Muscle Regeneration
Porcu, C., Dobrowolny, G., & Scicchitano, B. M. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25115811 · Cited by 33
Matrix Metalloproteinase Responsive Delivery of Myostatin Inhibitors
Braun, A. C., Gutmann, M., Ebert, R., Jakob, F. J., Gieseler, H., Lühmann, T. C., & Meinel, L. (2016) · Pharmaceutical Research · doi:10.1007/s11095-016-2038-6 · Cited by 35
Wang, Y., Mei, C., Su, X., Wang, H., Yang, W., & Zan, L. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20112748 · Cited by 28
Hsieh, S., Lin, H., Chen, C., Jhuo, C., Liao, K., Chen, W., & Tzen, J. T. C. (2019) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2019.108893 · Cited by 29
Ahn, J., Ha, T. Y., Ahn, J., Jung, C. H., Seo, H., Kim, M. J., Kim, Y., & Jang, Y. J. (2020) · The FASEB Journal · doi:10.1096/fj.201902399rr · Cited by 27
Liu, Y., Li, D., Wei, Y., Ma, Y., Wang, Y., Huang, L., & Wang, Y. (2020) · Journal of Food Biochemistry · doi:10.1111/jfbc.13461 · Cited by 33
Lee, D. H., & Goldberg, A. L. (2022) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2122482119 · Cited by 35
Self-citationYang, X., Mei, C., Raza, S. H. A., Ma, X., Wang, J., Du, J., & Zan, L. (2022) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2022.11.081 · Cited by 28
Palliative Care of Cancer in the Older Patient
Balducci, L., & Dolan, D. E. (2016) · Current Oncology Reports · doi:10.1007/s11912-016-0557-2 · Cited by 29
Ishida, J., Saitoh, M., Doehner, W., von Haehling, S., Anker, M. S., Anker, S. D., & Springer, J. (2017) · International Journal of Cardiology · doi:10.1016/j.ijcard.2017.03.154 · Cited by 30
Systemic IL-6 regulation of eccentric contraction-induced muscle protein synthesis
Hardee, J. P., Fix, D. K., Wang, X., Goldsmith, E. C., Koh, H., & Carson, J. A. (2018) · American Journal of Physiology-Cell Physiology · doi:10.1152/ajpcell.00063.2018 · Cited by 32
Lee, H., Lee, S.-J., Bae, G.-U., Baek, N.-I., & Ryu, J.-H. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18122748 · Cited by 26
Non-Pharmacological Strategies for Managing Sarcopenia in Chronic Diseases
Hu, J., Wang, Y., Ji, X., Zhang, Y., Li, K., & Huang, F. (2024) · Clinical Interventions in Aging · doi:10.2147/cia.s455736 · Cited by 33
Reduced muscle mass in middle-aged depressed patients is associated with male gender and chronicity
Kahl, K. G., Utanir, F., Schweiger, U., Krüger, T. H. C., Frieling, H., Bleich, S., Gutberlet, M., & Hartung, D. (2017) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2017.01.009 · Cited by 26
Ordan, M., Mazza, C., Barbe, C., Perrier, M., Botsen, D., Renard, Y., Moreau, J., Brasseur, M., Taillière, B., Bertin, É., et al. (2017) · Cancer · doi:10.1002/cncr.31207 · Cited by 33
Kim, J.-H., Aydemir, T. B., Jimenez, F. R., Ruggiero, C. H., Kim, M., & Cousins, R. J. (2020) · Scientific Reports · doi:10.1038/s41598-020-61059-2 · Cited by 28
Shin, Y. J., Kwon, E., Lee, S. M., Kim, S., Min, K., Lim, J., Lee, B., Kang, J. S., Kwak, J. Y., Son, Y. H., et al. (2020) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12578 · Cited by 28
Graça, F. A., Sheffield, N., Puppa, M., Finkelstein, D., Hunt, L. C., & Demontis, F. (2021) · PLoS Genetics · doi:10.1371/journal.pgen.1009926 · Cited by 28
Meng, X., Huang, Z., Inoue, A., Wang, H., Wan, Y., Yue, X., Xu, S., Jin, X., Shi, G., Kuzuya, M., et al. (2022) · Journal of Cachexia Sarcopenia and Muscle · doi:10.1002/jcsm.12919 · Cited by 29
Metadata
- Authors
- Cohen, S., Nathan, J. A., & Goldberg, A. L.
- Affiliations
- Technion – Israel Institute of Technology (IL)
- University of Cambridge (GB)
- Harvard University (US)
- Corresponding author
- Cohen, Shenhav
- Goldberg, Alfred L.
- Venue
- Nature Reviews Drug Discovery
- Published
- 2014-12-31
- Volume
- 14
- Issue
- 1
- Pages
- 58-74
- ISSN
- 1474-1776 (ISSN-L)
- 1474-1784
- OpenAlex
- W1998867833
- Cited by
- 1,089
- References
- 257
- Citations by year
- 2026: 75 · 2025: 92 · 2024: 92 · 2023: 111 · 2022: 110 · 2021: 111 · 2020: 117 · 2019: 88 · 2018: 91 · 2017: 86 · 2016: 79 · 2015: 36
- FWCI
- 6.32
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Nature Reviews Drug Discovery (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Wellcome Trust (100140, 102770, 102770/Z/13/Z)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (AR055255, R01AR055255)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Muscle Physiology and Disorders
- Health Sciences › Medicine › Physiology (medical) › Nutrition and Health in Aging
- Health Sciences › Nursing › Nutrition and Dietetics › Muscle metabolism and nutrition
- Keywords
- muscle atrophy, sarcopenia, cancer cachexia, sepsis, denervation, immobilization, protein synthesis, protein degradation, myostatin, cytokines, exercise therapy, therapeutic agents, chronic obstructive pulmonary disease, diabetes mellitus, renal failure, heart failure, Cushing's syndrome
- MeSH terms
- Animals, Humans, Muscular Atrophy, Myofibrils, Quality of Life, Signal Transduction, Sepsis, Wasting Syndrome, Myostatin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.